M&A Deal Summary

Invaio Sciences Acquires Peptyde Bio

On December 7, 2023, Invaio Sciences acquired agriculture company Peptyde Bio

Acquisition Highlights
  • This is Invaio Sciences’ 1st transaction in the Agriculture sector.
  • This is Invaio Sciences’ 1st transaction in the United States.
  • This is Invaio Sciences’ 1st transaction in Missouri.

M&A Deal Summary
Date 2023-12-07
Target Peptyde Bio
Sector Agriculture
Buyer(s) Invaio Sciences
Deal Type Add-on Acquisition

Target

Peptyde Bio

St. Louis, Missouri, United States
Peptyde Bio is an Agtech startup that discovers, designs, and characterizes novel anti-microbial peptides. These peptides can complement or replace chemical fungicides because they are effective, environmentally friendly, and have a lower cost of development compared to traditional fungicides. Peptyde Bio is based in St. Louis, Missouri.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Invaio Sciences

Cambridge, Massachusetts, United States
Category Company
Sector Agriculture
DESCRIPTION

Invaio Sciences is a bio-platform company that builds on advances in human health and digital innovation to develop biological technologies for crop health, enabling farmers to both improve yields and use more natural crop health solutions. The company addresses consumer demands and unlocks radical benefits for farmers and the environment, leaving every acre better today and for generations to come. Invaio Sciences is based in Cambridge, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector (Agriculture) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Missouri) 1 of 1
Country (United States) 1 of 1
Year (2023) 1 of 1
Mergr

Product

Company

Legal